BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:AMVUTTRA (Vutrisiran) readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of AMVUTTRA (Vutrisiran)\, from ClinicalTria
 ls.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06679946-10756@assetmemo.bio
DTSTAMP:20261121T005632Z
DTSTART;VALUE=DATE:20280331
DTEND;VALUE=DATE:20280401
SUMMARY:AMVUTTRA (Vutrisiran): Phase 3 readout est. (NCT06679946)
DESCRIPTION:AMVUTTRA (Vutrisiran)\, phase 3\, Transthyretin Amyloidosis wit
 h Cardiomyopathy.\nStudy: A Study to Evaluate Vutrisiran in Patients With 
 Transthyretin Amyloidosis With Cardiomyopathy\nEstimated primary completio
 n: 31 March 2028. This is a ClinicalTrials.gov estimate\, not a confirmed 
 readout date\, and it can move.\nDrug page: https://assetmemo.bio/drug/vut
 risiran#upcoming-events\nRegistry record: https://clinicaltrials.gov/study
 /NCT06679946
URL:https://assetmemo.bio/drug/vutrisiran#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
